Risuteganib improves visual acuity in patients with dry AMD in phase 2a study

risuteganib improves visual acuity in patients with dry amd in phase 2a study

Sumary of Risuteganib improves visual acuity in patients with dry AMD in phase 2a study:

  • November 18, 2021 1 min read Source/Disclosures Published by: Source: Karageozian V.
  • Targeting vision improvement in intermediate dry AMD with risuteganib.
  • Back to Healio NEW ORLEANS — Patients with intermediate dry age-related macular degeneration experienced meaningful improvement in visual acuity after treatment with risuteganib, according to a study.
  • Additionally, 32% of patients in the risuteganib group experienced at least 10 letters of improvement and 20% experienced at least 15 letters of improvement compared with 7.1% and 0% in the sham group, respectively.
  • “The better the outer retinal thickness is, the more likely you are to get a visual acuity improvement.

Want to know more click here go to source.

From -

Close

Site Language


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close